| Literature DB >> 29482652 |
C Noblet1,2, G Delpon3,4, S Supiot4,5, V Potiron4,6, F Paris4,6, S Chiavassa3,4.
Abstract
BACKGROUND: In pre-clinical animal experiments, radiation delivery is usually delivered with kV photon beams, in contrast to the MV beams used in clinical irradiation, because of the small size of the animals. At this medium energy range, however, the contribution of the photoelectric effect to absorbed dose is significant. Accurate dose calculation therefore requires a more detailed tissue definition because both density (ρ) and elemental composition (Zeff) affect the dose distribution. Moreover, when applied to cone beam CT (CBCT) acquisitions, the stoichiometric calibration of HU becomes inefficient as it is designed for highly collimated fan beam CT acquisitions. In this study, we propose an automatic tissue segmentation method of CBCT imaging that assigns both density (ρ) and elemental composition (Zeff) in small animal dose calculation.Entities:
Keywords: Monte Carlo simulations; Pre-clinical radiation therapy; Tissue segmentation
Mesh:
Year: 2018 PMID: 29482652 PMCID: PMC5828405 DOI: 10.1186/s13014-018-0971-8
Source DB: PubMed Journal: Radiat Oncol ISSN: 1748-717X Impact factor: 3.481
Fig. 1CBCT number variation with the product of physical density ρ and effective atomic number Zeff. Each x represents a different insert from the Gammex-RMI phantom. The solid line represents the third degree polynomial fitting curve
Tissues from ICRU report 44 [12] and 46 [13]
| ICRU tissues | Physical density ρ (g.cm3) | Zeff | ρZeff |
|---|---|---|---|
| Lung inflated | 0.26 | 7.88 | 2.05 |
| Adipose | 0.95 | 6.67 | 6.34 |
| Yellow marrow | 0.98 | 6.56 | 6.43 |
| Average soft tissue adult female | 1.02 | 7.44 | 7.59 |
| Red marrow | 1.03 | 7.44 | 7.66 |
| Water | 1.00 | 7.73 | 7.73 |
| Average soft tissue adult male | 1.03 | 7.60 | 7.83 |
| GI tract | 1.03 | 7.71 | 7.94 |
| Pancreas | 1.04 | 7.70 | 8.01 |
| Breast | 1.02 | 7.88 | 8.04 |
| Eyes lens | 1.07 | 7.54 | 8.07 |
| Lymph | 1.03 | 7.84 | 8.07 |
| Testis | 1.04 | 7.82 | 8.13 |
| Brain | 1.04 | 7.88 | 8.19 |
| Urinary bladder filled | 1.03 | 7.98 | 8.22 |
| Kidney | 1.05 | 7.84 | 8.23 |
| Ovary | 1.05 | 7.84 | 8.24 |
| Muscle | 1.05 | 7.85 | 8.24 |
| Lung deflated | 1.05 | 7.88 | 8.27 |
| Skin | 1.09 | 7.63 | 8.31 |
| Liver | 1.06 | 7.87 | 8.34 |
| Spleen | 1.06 | 7.87 | 8.34 |
| Heart | 1.06 | 7.95 | 8.43 |
| Blood | 1.06 | 7.97 | 8.45 |
| Cartillage | 1.10 | 8.33 | 9.16 |
| Thyroid | 1.05 | 9.19 | 9.65 |
| Spongiosa | 1.18 | 10.74 | 12.68 |
| Sacrum | 1.29 | 11.46 | 14.79 |
| Femur | 1.33 | 12.09 | 16.08 |
| Humerus | 1.46 | 12.61 | 18.41 |
| Cranium | 1.61 | 13.13 | 21.14 |
| Mandible | 1.68 | 13.33 | 22.40 |
| Cortical bone 5 year Child | 1.75 | 13.56 | 23.72 |
| Cortical bone | 1.92 | 13.98 | 26.84 |
Fig. 2Transmitted dose through the tissue substitute cylinders measured with an EBT3 film. Five minutes of irradiation were performed with an anterior 2 cm diameter beam at 225kVp
Fig. 3Measured versus calculated CBCT values with the stoichiometric and the ρZeff assignment methods
Fig. 4ρZeff variation with absorbed dose in ICRU tissues (see Table 1). MC dose calculations were performed for an anterior 5 mm 225kVp beam in a 5x5x5cm3 water tank with a 5 mm thick tissue insert at 1.5 cm depth in water. Absorbed dose in tissue was normalized to absorbed dose at the same position in the homogeneous water tank. This plot shows that a 0.2 ρZeff interval between two neighboring tissues is required to reach approximately 2% dose calculation precision
Transmitted dose through tissue substitute materials, measured and simulated with manufacturer’s data (Gammex) and the ρZeff tissue assignment method. EBT3 measurement uncertainty was 3.2% [10]
| Manufacturer’s data | ρZeff based tissue assignation method | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Tissue substitutes | EBT3 (Gy) | MC dose (Gy) | Stat. Uncert. | MC/EBT3 relative difference | MC/EBT3 absolute difference (Gy) | MC Dose (Gy) | Stat. Uncert. | MC/EBT3 relative difference | MC/EBT3 absolute difference (Gy) |
| CT solid water | 4.58 | 4.61 | 1.4% | 0.5% | 0.03 | 4.51 | 1.3% | −1.5% | −0.07 |
| Inner bone | 3.44 | 3.50 | 1.5% | 1.7% | 0.06 | 3.41 | 1.5% | −1.0% | −0.03 |
| Cortical bone | 1.40 | 1.38 | 2.0% | −1.8% | −0.02 | 1.42 | 2.1% | 1.3% | 0.02 |
| CB2 50% | 1.99 | 1.93 | 1.8% | −3.0% | −0.06 | 2.02 | 1.8% | 1.5% | 0.03 |
| CB2 30% | 2.73 | 2.72 | 1.6% | −0.4% | −0.01 | 2.80 | 1.6% | 2.6% | 0.07 |
| Breast | 4.93 | 4.91 | 1.3% | −0.4% | −0.02 | 4.75 | 1.3% | −3.6% | −0.18 |
| B200-bone | 3.41 | 3.49 | 1.5% | 2.4% | 0.08 | 3.45 | 1.5% | 1.1% | 0.04 |
| Adipose | 5.29 | 5.35 | 1.3% | 1.3% | 0.07 | 5.29 | 1.3% | 0.1% | 0.01 |
Fig. 5a Absorbed dose distribution in mouse (axial section). Transmitted dose through the mouse measured in coronal plane with b EBT3 film and c computed by MC calculations. EBT3 uncertainty was 3.2%. MC statistical uncertainty was lower than 1.5%
Fig. 6a Absorbed dose difference (Gy) between EBT3 and MC results. b Relative dose difference (%) between EBT3 and MC results performed inside the 80% isodose area. c Gamma analysis performed with 4% DD and 0.3 mm DTA, revealing a success rate of 94.9%. d Measured and calculated horizontal dose profiles along a diameter plotted with the dashed line on (c)